Pfizer is working on a new vaccine for Coronavirus that has a 90% efficacy rate. Be that good news as it may, but here’s what you need to know more about it!
1. Difference Between Efficacy And Effective Rates
Efficacy rates refer to the maximum response achievable from a pharmaceutical drug in research settings. In that case, yes the vaccine has a 90% rate. However, effectiveness means how many people it can cure per se. The vaccine’s effective rate is questionable because currently, it is working under completely controlled settings. Would it work in real-life scenarios? We have yet to find out.
2. Problems With Supply Chain
Most effective and promising vaccines require constant and extremely cold storage. In poorer areas where there are no roads let alone cool storage facilities, transferring the vaccine will be difficult. There are areas where access to electricity is unreliable or missing altogether or there aren’t enough health facilities with the required refrigeration capacity.
3. The Exclusivity Of The Vaccine
Almost 3 billion people in low-income countries across Africa, Asia and Latin America will most likely be unable to access the COVID-19 vaccine. This can be the case for years after it becomes available.
4. The Hope
As of October 2020, the World Bank planned to provide US$12 billion. These funds will be used to finance vaccine acquisition and deployment in low- and middle-income countries.
Stay tuned to Brand Voice for more news and updates!